LANXESS Q1 sales up 43.7 percent to EUR 2.432 billion

Mumbai (Maharashtra) [India], May 11: Specialty Chemicals company LANXESS made a strong start to the year 2022. In the first quarter of 2022, EBITDA pre exceptionals increased considerably and amounted to EUR 320 million, 32.2 percent higher than the previous year’s figure of EUR 242 million. All the company’s segments contributed to the growth, with the Specialty Additives segment performing particularly well. LANXESS passed on the significantly increased raw material and energy costs via higher selling prices. The successful acquisitions, especially that of Emerald Kalama Chemical, likewise made a positive earnings contribution. The EBITDA margin pre exceptionals came to 13.2 percent, against 14.3 percent a year ago.

Group sales amounted to EUR 2.432 billion in the first quarter, up 43.7 percent on the previous year’s figure of EUR 1.693 billion. Net income reached EUR 98 million, after net income from continuing operations of EUR 63 million in the previous year.

LANXESS is also confident going into the second quarter, in which the Group expects EBITDA pre exceptionals of between EUR 280 million and EUR 350 million. In the prior-year quarter, the company had generated EUR 277 million. For the full year, LANXESS still expects EBITDA pre exceptionals to be significantly higher than in the previous year. However, the guidance does not take into account potential further impacts of the war in Ukraine and the contribution of the acquisition of IFF’s Microbial Control business. The transaction is expected to close in the third quarter.

“With our focus on specialty chemicals, we have built up strong market positions in recent years, which are particularly paying off in the current situation. We can thus pass on higher raw material and energy costs via our selling prices. However, it is impossible to predict the impact of the war in Ukraine on future business performance. We are therefore monitoring the further developments very closely,” said Matthias Zachert, Chairman of the Board of Management of LANXESS AG.

Comments are closed.

Business

Automation Expo South 2025: South India’s Premier Event for Industrial Automation, AI and Robotics

Chennai (Tamil Nadu) [India], February 18:  With industries embracing automation, AI, and robotics at an unprecedented pace, Automation Expo South 2025 stands as the definitive platform to explore groundbreaking solutions shaping the future of manufacturing, industrial automation, and digital transformation. Taking place from 6th to 8th March 2025 at the Chennai Trade Centre, the event […]

Read More
Business

Abakkus Leads Rs. 175 Crore Funding in Stelmec Limited with Hem Securities Ltd. as Lead Advisor

New Delhi [India], February 18: Mumbai based Stelmec Limited, a three decade-old name synonymous with Electrical Power Products in India and a trusted partner to various State Owned and Private Power Utilities, has secured ₹175 crore from a consortium led by Abakkus Four2Eight Opportunities Fund. The transaction was facilitated, Hem Securities Ltd., who played a pivotal role in […]

Read More
Business

Giosun Healthcare Sets New Standards in Ayurvedic Wellness at IPLCM Expo 2025

New Delhi [India], February 17: Giosun Healthcare Private Limited, a leading innovator in herbal cosmetics, personal care, and nutraceuticals, made a significant impact at the International Private Label & Contract Manufacturing (IPLCM) Expo 2025 held at the Bombay Exhibition Centre. With a portfolio of over 700 natural wellness products, the company reaffirmed its dedication to […]

Read More